Management of complications encountered with Essure hysteroscopic sterilization: a systematic review.
Essure hysteroscopic sterilization has been US Food and Drug Administration-approved in the United States since 2002. Complications associated with the Essure device include improper placement (malpositioning), unintended pregnancy, pain, infection, and nickel allergy. The rarity of complications, compounded by underreporting, makes it difficult to determine best practices insofar as management. This systematic review synthesizes the national and global experience with management of Essure-related complications and suggests treatment options when data allow.
Department of Obstetrics and Gynecology, University of Utah, Salt Lake City. Electronic address: marisa.adelman@hsc.utah.edu.
Marisa R
MR
Adelman
Department of Obstetrics and Gynecology, University of Utah, Salt Lake City.
Mark W
MW
Dassel
Department of Obstetrics and Gynecology, University of Utah, Salt Lake City.
Howard T
HT
Sharp
D000328:Adult; D059350:Chronic Pain / Q000209:etiology; D004868:Equipment Failure; D005260:Female; D006801:Humans; D006967:Hypersensitivity / Q000209:etiology*; D015907:Hysteroscopy / Q000009:adverse effects* / Q000295:instrumentation*; D019300:Medical Errors; D009532:Nickel / Q000009:adverse effects*; D011247:Pregnancy; D011271:Pregnancy, Ectopic / Q000209:etiology*; D049168:Pregnancy, Unplanned; D012189:Retrospective Studies; D013246:Sterilization, Tubal / Q000009:adverse effects* / Q000295:instrumentation*; D017211:Treatment Failure; D014481:United States
D009532:Nickel
Chronic pain; Complication; Essure; Hysteroscopic sterilization; Malposition